Works matching IS 00126667 AND DT 2022 AND VI 82 AND IP 5

Results: 10
    1
    2

    Sugemalimab: First Approval.

    Published in:
    Drugs, 2022, v. 82, n. 5, p. 593, doi. 10.1007/s40265-022-01693-4
    By:
    • Dhillon, Sohita;
    • Duggan, Sean
    Publication type:
    Article
    3
    4

    Contemporary Management of Dyslipidemia.

    Published in:
    Drugs, 2022, v. 82, n. 5, p. 559, doi. 10.1007/s40265-022-01691-6
    By:
    • Ferraro, Richard A.;
    • Leucker, Thorsten;
    • Martin, Seth S.;
    • Banach, Maciej;
    • Jones, Steven R.;
    • Toth, Peter P.
    Publication type:
    Article
    5
    6

    Daridorexant: First Approval.

    Published in:
    Drugs, 2022, v. 82, n. 5, p. 601, doi. 10.1007/s40265-022-01699-y
    By:
    • Markham, Anthony
    Publication type:
    Article
    7
    8
    9

    Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.

    Published in:
    Drugs, 2022, v. 82, n. 5, p. 533, doi. 10.1007/s40265-022-01688-1
    By:
    • Zhanel, George G.;
    • Pozdirca, Marianna;
    • Golden, Alyssa R.;
    • Lawrence, Courtney K.;
    • Zelenitsky, Sheryl;
    • Berry, Liam;
    • Schweizer, Frank;
    • Bay, Denice;
    • Adam, Heather;
    • Zhanel, Michael A.;
    • Lagacé-Wiens, Philippe;
    • Walkty, Andrew;
    • Irfan, Neal;
    • Naber, Kurt;
    • Lynch III, Joseph P.;
    • Karlowsky, James A.
    Publication type:
    Article
    10